Profiling IL-2R and IL-7R subunit abundance of healthy controls and COVID-19 patients during acute infection (Acute), 6 months (6 M follow-up) and 12 months after clinical recovery (12 M follow-up) revealed prolonged changes in these receptors, most notably in the T cell compartment. The gene discussed is IL7R; the disease is COVID-19.